Modification of Alternative Splicing of Bcl-x Pre-mRNA in Prostate and Breast Cancer Cells
Open Access
- 1 May 2001
- journal article
- research article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (19), 16411-16417
- https://doi.org/10.1074/jbc.m009256200
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Relative level of expression of Bax and Bcl-XL determines the cellular fate of apoptosis/necrosis induced by the overexpression of BaxOncogene, 1999
- Inhibition of Bcl-xL expression sensitizes normal human keratinocytes and epithelial cells to apoptotic stimuliOncogene, 1999
- The Bcl-2 Protein Family: Arbiters of Cell SurvivalScience, 1998
- Bcl-xL Modulates Apoptosis Induced by Anticancer Drugs and Delays DEVDase and DNA Fragmentation-Promoting ActivitiesExperimental Cell Research, 1998
- Baculovirus p35 and Z-VAD-fmk inhibit thapsigargin-induced apoptosis of breast cancer cellsOncogene, 1997
- A Specificity Comparison of Four Antisense Types: Morpholino, 2′-O-Methyl RNA, DNA, and Phosphorothioate DNAAntisense and Nucleic Acid Drug Development, 1997
- Bcl-xS Antagonizes the Protective Effects of Bcl-xLJournal of Biological Chemistry, 1996
- bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell deathCell, 1993
- ApoptosisImmunology Today, 1993
- Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activationNature, 1980